Skip to main content
. 2022 Mar 28;34(3):276–286. doi: 10.4103/tcmj.tcmj_318_21

Figure 3.

Figure 3

Examples of approved drugs with potential for repurposing to treat severe acute respiratory syndrome coronavirus 2 infection. (a) omipalisib. (b) rifampicin. (c) letermovir